Tag

melasma treatment

SOCU Faculty Research: Thiamidol for Hyperpigmentation

By Skin of Color Update Agenda

hyperpigmentation

Skin of Color Update faculty are experts in skin of color dermatology. Eight faculty members were involved with this recent Journal of Drugs in Dermatology article on Thiamidol as a treatment for hyperpigmentation.

Drs. Cheri Frey, Pearl Grimes, Valerie Callender, Andrew Alexis, Hilary Baldwin, Nada Elbuluk, Susan Taylor, and Seemal Desai conducted the review of pre-clinical and clinical safety and efficacy data of Thiamidol formulations. Thiamidol or isobutylamido thiazolyl resorcinol, has been identified as the most effective human tyrosinase inhibitor out of 50,000 compounds screened. The researchers wrote that Thiamidol appears to be safe and effective and should be considered when recommending over-the-counter treatment options to patients with hyperpigmentation.

For the latest research and updates in the treatment of hyperpigmentation, attend Skin of Color Update. Register today!

JDD Buzz: Diversity in Melasma Clinical Trials

By SOC Manuscripts

diversity in melasma clinical trials

A recent Journal of Drugs in Dermatology study looked at the diversity of patients enrolled in melasma clinical trials to determine if there are any disparities in representation.

Read this interview with author Jared Jagdeo, MD, MS, associate professor of dermatology and director of the Center for Photomedicine at SUNY Downstate Medical Center. Learn Dr. Jagdeo’s key takeaways from the study and hear his advice for researchers in increasing representation in a study population.

Register for Skin of Color Update 2025 and learn the latest in the pathogenesis, diagnosis, and treatment of melasma.